Zentiva Group Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Public

  • Employees
  • 4,800

Employees

  • Stock Symbol
  • 1SKF401E

Stock Symbol

  • Investments
  • 11

  • Share Price
  • $34.43
  • (As of Thursday Closing)

Zentiva Group General Information

Description

Zentiva AS is engaged in the development, production, and distribution of generic medicines. It operates in more than 25 European markets. The company therapeutic areas inlcude Cardiovascular, Central nervous system, Gastrointestinal and metabolic disorders, Anti-inflammatory and pain, Ophthalmology, Anti-infectives, Urology, Respiratory, Blood disorders, and Oncology.

Contact Information

Website
www.zentiva.com
Formerly Known As
Leciva
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Corporate Office
  • U Kabelovny 529/16
  • Dolní Měcholupy
  • Prague, 102 00
  • Czech Republic
+420 267
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
XBRA
Corporate Office
  • U Kabelovny 529/16
  • Dolní Měcholupy
  • Prague, 102 00
  • Czech Republic
+420 267

Zentiva Group Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zentiva Group Stock Performance

As of 19-Jun-2025, Zentiva Group’s stock price is $34.43.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$34.43 $34.65 $25.03 - $35.94 4.14

Zentiva Group Financials Summary

As of 31-Dec-2015, Zentiva Group has a trailing 12-month revenue of $126M.

In Thousands,
USD
TTM 31-Dec-2015 FY 2015 31-Dec-2015 FY 2014 31-Dec-2014
Revenue 125,622 125,622 185,331
EBITDA 37,918 37,918 67,796
Net Income 19,452 19,452 53,052
Total Assets 149,351 149,351 191,232
Total Debt 0 0 23
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Zentiva Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zentiva Group‘s full profile, request access.

Request a free trial

Zentiva Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Zentiva AS is engaged in the development, production, and distribution of generic medicines. It operates in more than 25
Drug Discovery
Prague, Czech Republic
4,800 As of 2025

New York, NY
 

Tokyo, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zentiva Group Competitors (84)

One of Zentiva Group’s 84 competitors is Anavex Life Sciences, a Corporation company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Anavex Life Sciences Corporation New York, NY
Astellas Pharma Corporation Tokyo, Japan
Merck & Co. Corporation Rahway, NJ
Gilead Sciences Formerly VC-backed Foster City, CA
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA
You’re viewing 5 of 84 competitors. Get the full list »

Zentiva Group Patents

Zentiva Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202418754-D0 Method for producing (s)-amlodipine succinate Pending 19-Dec-2024
GB-202407194-D0 Pending 21-May-2024
EP-4552633-A1 Pharmaceutical compositions comprising amorphous solid solutions of rivaroxaban and copovidone and preparation methods thereof Pending 10-Nov-2023
GB-202317232-D0 Pharmaceutical compositions comprising amorphous solid solutions of rivaroxaban and copovidone and preparation methods thereof Inactive 10-Nov-2023
EP-4505998-A1 Pharmaceutical composition containing dapagliflozin and metformin Pending 08-Aug-2023 A61K31/155
To view Zentiva Group’s complete patent history, request access »

Zentiva Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zentiva Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Zentiva Group‘s full profile, request access.

Request a free trial

Zentiva Group Investments & Acquisitions (11)

Zentiva Group’s most recent deal was a Buyout/LBO with Aboca (Five Heritage Brand). The deal was made on 16-Jun-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Aboca (Five Heritage Brand) 16-Jun-2025 Buyout/LBO Pharmaceuticals
Apontis Pharma 13-Jun-2025 Secondary Transaction - Private Pharmaceuticals
Apontis Pharma 09-Dec-2024 Buyout/LBO Pharmaceuticals
Blokurima 01-Nov-2024 Buyout/LBO Pharmaceuticals
Sanofi (Zerinol and Schoum Solution) 06-Dec-2022 Buyout/LBO Pharmaceuticals
You’re viewing 5 of 11 investments and acquisitions. Get the full list »

Zentiva Group Exits (1)

Zentiva Group’s most recent exit was on 11-Aug-2003 from Saneca Pharmaceuticals. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Saneca Pharmaceuticals 11-Aug-2003 Completed
  • 2 buyers
To view Zentiva Group’s complete exits history, request access »

Zentiva Group Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Apontis Pharma Monheim am Rhein, Germany 1946
Blokurima Prague, Czech Republic

Zentiva Group FAQs

  • When was Zentiva Group founded?

    Zentiva Group was founded in 1993.

  • Where is Zentiva Group headquartered?

    Zentiva Group is headquartered in Prague, Czech Republic.

  • What is the size of Zentiva Group?

    Zentiva Group has 4,800 total employees.

  • What industry is Zentiva Group in?

    Zentiva Group’s primary industry is Drug Discovery.

  • Is Zentiva Group a private or public company?

    Zentiva Group is a Public company.

  • What is Zentiva Group’s stock symbol?

    The ticker symbol for Zentiva Group is 1SKF401E.

  • What is the current stock price of Zentiva Group?

    As of 19-Jun-2025 the stock price of Zentiva Group is $34.43.

  • What is Zentiva Group’s current revenue?

    The trailing twelve month revenue for Zentiva Group is $126M.

  • Who are Zentiva Group’s competitors?

    Anavex Life Sciences, Astellas Pharma, Merck & Co., Gilead Sciences, and Dicerna Pharmaceuticals are some of the 84 competitors of Zentiva Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »